| scholarly article | Q13442814 |
| P2093 | author name string | Nacksung Kim | |
| Jung Ha Kim | |||
| P2860 | cites work | JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms | Q58326878 |
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand | Q64378984 | ||
| Administration of colony stimulating factor-1 corrects some macrophage, dental, and skeletal defects in an osteopetrotic mutation (toothless, tl) in the rat | Q68117985 | ||
| Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL) | Q73907464 | ||
| Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 | Q24300916 | ||
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| The PI3K-PDK1 connection: more than just a road to PKB | Q24531972 | ||
| Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 | Q24537518 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice | Q28140546 | ||
| TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src | Q28142620 | ||
| Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival | Q28142897 | ||
| Identification of a second Grb2 binding site in the v-Fms tyrosine kinase | Q28255340 | ||
| Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis | Q28267970 | ||
| Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase | Q28278061 | ||
| The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor | Q28285539 | ||
| Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 | ||
| SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts | Q28510858 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors | Q28513453 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Signaling to NF-kappaB | Q29547844 | ||
| Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
| Genetic regulation of osteoclast development and function | Q29617421 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism | Q30157499 | ||
| Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse | Q33646429 | ||
| Early events in M-CSF receptor signaling | Q33855769 | ||
| TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs | Q33864629 | ||
| Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling | Q33887555 | ||
| Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors | Q33965534 | ||
| A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine Phosphorylation | Q34489187 | ||
| Biology of the TRANCE axis | Q35145622 | ||
| Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
| Erk1 positively regulates osteoclast differentiation and bone resorptive activity | Q35227805 | ||
| T-cell receptor signal transmission: who gives an ITAM? | Q35557286 | ||
| Osteoclasts: New Insights | Q35755039 | ||
| Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807. | Q35922299 | ||
| The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis | Q36371653 | ||
| Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. | Q36400170 | ||
| I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss | Q36402985 | ||
| Bone quality--the material and structural basis of bone strength and fragility | Q36488553 | ||
| CSF-1 receptor structure/function in MacCsf1r-/- macrophages: regulation of proliferation, differentiation, and morphology | Q36838570 | ||
| RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
| The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase | Q37647341 | ||
| Colony-stimulating factor-1 receptor | Q37870336 | ||
| Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos | Q38342636 | ||
| Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade | Q38467858 | ||
| Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis | Q39714931 | ||
| Parallel signal processing among mammalian MAPKs | Q40501929 | ||
| PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility | Q40686068 | ||
| Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling | Q40756889 | ||
| CSF-I signal transduction: what is of functional significance? | Q41546313 | ||
| Autoamplification of NFATc1 expression determines its essential role in bone homeostasis | Q42972503 | ||
| Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects | Q43833399 | ||
| p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function | Q44072080 | ||
| Tyrosines 559 and 807 in the cytoplasmic tail of the macrophage colony-stimulating factor receptor play distinct roles in osteoclast differentiation and function | Q44226046 | ||
| Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis | Q46620740 | ||
| Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. | Q46711436 | ||
| Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis | Q47761859 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| c-Fms Tyrosine 559 Is a Major Mediator of M-CSF-induced Proliferation of Primary Macrophages | Q58085242 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12-7 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Chonnam Medical Journal | Q26842647 |
| P1476 | title | Signaling Pathways in Osteoclast Differentiation | |
| P478 | volume | 52 |
| Q36195181 | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study |
| Q90653768 | Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis |
| Q64237120 | Black Rice ( L.) Fermented with Attenuates Osteoclastogenesis and Ovariectomy-Induced Osteoporosis |
| Q91967069 | Creation of RANKL mutants with low affinity for decoy receptor OPG and their potential anti-fibrosis activity |
| Q90347790 | Deep Learning Implicitly Handles Tissue Specific Phenomena to Predict Tumor DNA Accessibility and Immune Activity |
| Q36939350 | Downregulation of Runx2 by 1,25-Dihydroxyvitamin D₃ Induces the Transdifferentiation of Osteoblasts to Adipocytes |
| Q38744409 | Effects of Dihydrophaseic Acid 3'-O-β-d-Glucopyranoside Isolated from Lycii radicis Cortex on Osteoblast Differentiation |
| Q90745020 | F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways |
| Q90567724 | From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights |
| Q37351205 | GATA4 negatively regulates bone sialoprotein expression in osteoblasts |
| Q90290403 | Hexane Fraction of Turbo brunneus Inhibits Intermediates of RANK-RANKL Signaling Pathway and Prevent Ovariectomy Induced Bone Loss |
| Q64262538 | I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma |
| Q64085314 | Interleukin-27 prevents LPS-induced inflammatory osteolysis by inhibiting osteoclast formation and function |
| Q90474952 | Isosteviol Derivative Inhibits Osteoclast Differentiation and Ameliorates Ovariectomy-Induced Osteoporosis |
| Q89977149 | METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export |
| Q58588319 | Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis |
| Q63762081 | Mandibular Bone Loss after Masticatory Muscles Intervention with Botulinum Toxin: An Approach from Basic Research to Clinical Findings |
| Q37729189 | Methyl Gallate Inhibits Osteoclast Formation and Function by Suppressing Akt and Btk-PLCγ2-Ca2+ Signaling and Prevents Lipopolysaccharide-Induced Bone Loss. |
| Q47796713 | Novel RANKL DE-loop mutants antagonize RANK-mediated osteoclastogenesis |
| Q39190775 | Osteoblast-osteoclast interactions |
| Q49907069 | Paeoniflorin ameliorates collagen-induced arthritis via suppressing NF-κB signaling pathway in osteoclast differentiation. |
| Q60907427 | Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients |
| Q37472044 | RCANs regulate the convergent roles of NFATc1 in bone homeostasis |
| Q42371581 | Real-time in vivo imaging of metastatic bone tumors with a targeted near-infrared fluorophore |
| Q90659616 | Regulation of TRPV5 transcription and expression by E2/ERα signalling contributes to inhibition of osteoclastogenesis |
| Q92377250 | Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway |
| Q37148066 | STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis |
| Q89619982 | Signaling of the Purinergic System in the Joint |
| Q37330422 | Smad4 is required to inhibit osteoclastogenesis and maintain bone mass |
| Q58696619 | Tetrahydroxystilbene Glucoside Regulates Proliferation, Differentiation, and OPG/RANKL/M-CSF Expression in MC3T3-E1 Cells via the PI3K/Akt Pathway |
| Q92664754 | The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation |
| Q42378776 | The effects of downhill and uphill exercise training on osteogenesis-related factors in ovariectomy-induced bone loss |
| Q58586122 | Thy-1 Deficiency Augments Bone Loss in Obesity by Affecting Bone Formation and Resorption |
| Q42197175 | Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1. |
| Q90599354 | Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling |
| Q53733846 | [Effects of paeonol on the function of bone marrow-derived macrophage from Porphyromonas gingivalis-induced mice]. |
Search more.